This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -104.13M -110.21M -116.22M -101.78M
Operating Gains/Losses 0.00 0.00 0.00 -141.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 588.00K -1.03M 394.00K 488.00K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 3.12M -995.00K 10.36M -5.24M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital -447.00K -197.00K 319.00K -946.00K
Other Non-Cash Items 5.21M 16.38M 13.18M 9.19M
Net Cash From Continuing Operations -91.08M -94.46M -87.94M -82.37M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -91.08M -94.46M -87.94M -82.37M
Sale of Property, Plant & Equipment 130.00K 85.00K 2.62M 64.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 212.62M 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.72M -492.00K -1.21M -1.13M
Acquisitions 0.00 0.00 0.00 -5.56M
Purchases of Short-Term Investments -111.49M 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 176.63M 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 99.54M -97.81M 69.96M -113.84M
Issuance of Debt 0.00 0.00 0.00 11.38M
Cash Used for Financing Activities
Issuance of Capital Stock 1.08M 38.11M 160.78M 181.50M
Repayment of Long-Term Debt -1.57M -1.44M -3.59M -49.86M
Repurchase of Capital Stock -873.00K -285.00K -108.00K -149.00K
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -26.00K 0.00 0.00 0.00
Net Cash From Financing Activities -1.39M 36.38M 157.08M 142.87M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 7.08M -155.89M 139.10M -53.35M
LXRX News

LXRX Lexicon Pharmaceuticals Inc

Analysts Ratings for LXRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET LXRX ANALYST REPORT

Brokerage Partners

LXRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs